Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.180
-0.100 (-4.39%)
Nov 20, 2024, 4:00 PM EST - Market closed
Sunshine Biopharma Employees
Sunshine Biopharma had 44 employees as of December 31, 2023. The number of employees decreased by 2 or -4.35% compared to the previous year.
Employees
44
Change (1Y)
-2
Growth (1Y)
-4.35%
Revenue / Employee
$749,079
Profits / Employee
-$96,044
Market Cap
4.36M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Check-Cap | 85 |
Sharps Technology | 57 |
Predictive Oncology | 35 |
Genprex | 26 |
Purple Biotech | 20 |
Galmed Pharmaceuticals | 8 |
Portage Biotech | 7 |
Creative Medical Technology Holdings | 4 |
SBFM News
- 14 days ago - Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - Accesswire
- 7 weeks ago - Sunshine Biopharma Launches Two New Generic Prescription Drugs - Accesswire
- 2 months ago - Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry - Accesswire
- 3 months ago - Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada - Accesswire
- 3 months ago - Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61% - Accesswire
- 3 months ago - Sunshine Biopharma Announces Reverse Stock Split - Accesswire
- 7 months ago - Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) - Accesswire
- 8 months ago - Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023 - Accesswire